Life Sciences: IP/Patent Litigation - California
Band 2
What the Team is Known For
Perkins Coie LLP represents clients in relation to the management of IP portfolios, including freedom to operate analysis, patent prosecution, due diligence and enforcement actions. The team is also noted for its adept handling of corporate transactions, licensing deals, strategic partnerships and capital markets offerings. The team also assists with PTAB proceedings and advises on FDA compliance matters.
Strengths
Perkins has a depth of understanding in biotechnology.
Perkins Coie has knowledgeable and responsive employees who are highly experienced.
The Mintz team is efficient, responsive and offers solid expertise in specific subject matter areas.
The group's service levels and responsiveness are outstanding. The team is proactive in addressing any issues and is always quick to respond.
Perkins Coie is extremely knowledgeable and offers full service, global IP support. The attorneys bring real passion to their work.
Work Highlights
Perkins Coie LLP represented Gator Bio on intellectual property matters, including patent litigation, patent prosecution and trademarks.
Notable practitioners
Michael Wise's experience includes handling a broad range of patent concerns for life sciences sector clients. He chairs the firm's life sciences group and advises clients from a range of industries, including medical devices and software.
Michael offers excellent client service with sophistication and strong commercial insight.
Michael provides highly responsive, thoughtful and reliable support. He delivers sophisticated, strategic guidance on complex IP matters, remaining aligned with commercial goals.
Viola Kung regularly advises clients in the biotech, chemical and pharmaceutical fields both nationally and internationally on an array of matters, particularly patent prosecution and portfolio management.
Viola is knowledgeable in science, easy to work with and very fast at what she does.
Mark Wicker represents established and emerging clients in the life science industry. Boasting significant corporate experience, he provides expertise on strategic partnerships, licensing agreements and joint ventures.
Mark is extraordinary in pharma and biotech agreements. He has knowledge, judgment and invaluable market expertise.
